Profile
Jeffrey M.
Salzman worked as Head-Reimbursement at Quest Diagnostics, Monogram Biosciences, Aspira Women's Health, CareDx, and Diadexus.
He also worked as Vice President-Managed Care & Payer Relations at Interpace Biosciences.
Salzman completed his undergraduate degree at Florida State University and his graduate degree at St. Thomas University (Florida).
Former positions of Jeffrey M. Salzman
| Companies | Position | End |
|---|---|---|
| CAREDX, INC | Corporate Officer/Principal | 31/12/2019 |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | - |
| DIADEXUS, INC. | Corporate Officer/Principal | - |
| INTERPACE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Jeffrey M. Salzman
| St. Thomas University (Florida) | Graduate Degree |
| Florida State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| CAREDX, INC | Health Technology |
| QUEST DIAGNOSTICS INCORPORATED | Health Services |
| Private companies | 2 |
|---|---|
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Jeffrey M. Salzman
